Syros Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
34.20
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-4.01
|
-3.21
|
0.80
|
19.95%
|
|
2022-06-30
|
-4.08
|
-5.40
|
-1.32
|
-32.35%
|
|
2022-03-31
|
-4.70
|
-4.00
|
0.70
|
14.89%
|
|
2021-12-31
|
-4.66
|
-3.80
|
0.86
|
18.45%
|
|
2021-09-30
|
-4.40
|
-4.10
|
0.30
|
6.82%
|
|
2021-06-30
|
-3.72
|
-3.60
|
0.12
|
3.23%
|
|
2021-03-31
|
-4.65
|
-2.30
|
2.35
|
50.54%
|
|
2020-12-31
|
-4.99
|
-6.20
|
-1.21
|
-24.25%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-12.61
|
|
2021-12-31
|
-13.80
|
|
2020-12-31
|
-11.27
|
|
2019-12-31
|
-1.89
|
|
2018-12-31
|
-1.92
|
|
2017-12-31
|
-2.13
|
|
2016-12-31
|
-6.54
|